• IMSN Neuromuscular Blocker Safety Interest Group Charter Read on…

• IMSN Neuromuscular Blocker SIG Members List Read on…

• Minutes
  taken by Tyler Nichols, ISMP International Medication Safety Management Fellow

Agenda

• Welcome
• Introductions (new members)
• Approval of Charter
• Country Presentations
• • Canada
    ISMP Canada update
    Sylvia Hyland
  • ISMP US
    Lessons Learned about Human Fallibility, System Design, and Justice in the Aftermath of a Fatal Medication Error: Opportunities for Improvement
    Mike Cohen
• Next Steps

• Minutes
• Saudi FDA
  Neuromuscular Blockers: Safety Measures and Labeling Requirements
  Ghadeer M. Banasser

• Minutes
• France
  Neuromuscular blockers and medication errors : A 10-year pharmacovigilance review
  Marie-Blanche Valnet Rabier for the French PV network
• France (continued)
  Neuromuscular blockers errors in France
  Étienne Schmitt
• Abu Dhabi Department of Health
  Neuromuscular Blocker (NMB) Gaps and Solutions
  Dr. Nahed Ali AlRaeesi

• Minutes
• Canada
  Update from Health Canada
  Kristy Shortall-Cain
• Colombia - ACQFH (Colombian Society of Hospital Pharmacists)
  Medication Safety Use of NMBs in Colombia:
  The view of the ACQFH medication safety use chapter
  Claudia Pulido

• Minutes
• Spain
  Neuromuscular Blocking Agent Safety: ISMP-Spain Update
  María José Otero
• Ireland
  Neuromuscular Blocking Agent Safety: Irish Medication Safety Network Update
  Geraldine Creaton